IgG4-related disease in Italy: Clinical features and outcomes of a large cohort of patients

Scandinavian Journal of Rheumatology

Volumn 45, Issue 2, 2016, Pages 135-145

  Campochiaro, C ^a   Ramirez, G A ^a   Bozzolo, E P ^a   Lanzillotta, M ^a   Berti, A ^a   Baldissera, E ^a   Dagna, L ^a   Praderio, L ^a   Scotti, R ^a   Tresoldi, M ^a   Roveri, L ^a   Mariani, A ^a   Balzano, G ^a   Castoldi, R ^a   Doglioni, C ^a   Sabbadini, M G ^a   Della Torre, E ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; IMMUNOGLOBULIN G4; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLATE MOFETIL; PREDNISONE; RITUXIMAB; IMMUNOGLOBULIN G;

ADULT; AGED; ARTICLE; ATOPY; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CYTOREDUCTIVE SURGERY; DISEASE ACTIVITY; FEMALE; FOLLOW UP; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN G4 RELATED DISEASE; ITALIAN (CITIZEN); MALE; ORBIT PSEUDOTUMOR; PANCREAS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RELAPSE; REMISSION; RETROPERITONEUM; SALIVARY GLAND; TREATMENT DURATION; TREATMENT RESPONSE; AUTOIMMUNE DISEASES; COMPLICATION; IMMUNOLOGY; ITALY; MIDDLE AGED; ORBITAL PSEUDOTUMOR; PANCREATITIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; SIALADENITIS;

AGED; AUTOIMMUNE DISEASES; COHORT STUDIES; CYTOREDUCTION SURGICAL PROCEDURES; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; ITALY; MALE; MIDDLE AGED; ORBITAL PSEUDOTUMOR; PANCREATITIS; RECURRENCE; REMISSION INDUCTION; RETROPERITONEAL SPACE; RETROSPECTIVE STUDIES; SIALADENITIS;

EID: 84960341600     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2015.1055796     Document Type: Article

References (38)

1. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med 2012; 366: 539-51.
2. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T., et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001; 344: 732-8.
3. Khosroshahi A, Carruthers MN, Stone JH, Shinagare S, Sainani N, Hasserjian RP., et al. Rethinking Ormonds disease: idiopathic retroperitoneal fibrosis in the era of IgG4-related disease. Medicine (Baltimore) 2013; 92: 82-91.
4. Lu LX, Della-Torre E, Stone JH, Clark SW. IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment. JAMA Neurol 2014; 71: 785-93.
5. Della-Torre E, Passerini G, Furlan R, Roveri L, Chieffo R, Anzalone N., et al. Cerebrospinal fluid analysis in immunoglobulin G4-related hypertrophic pachymeningitis. J Rheumatol 2013; 40: 1927-9.
6. Della-Torre E, Galli L, Franciotta D, Bozzolo EP, Briani C, Furlan R., et al. Diagnostic value of IgG4 indices in IgG4-related hypertrophic pachymeningitis. J Neuroimmunol 2014; 266: 82-6.
7. Della Torre E, Bozzolo EP, Passerini G, Doglioni C, Sabbadini MG. IgG4-related pachymeningitis: evidence of intrathecal IgG4 on cerebrospinal fluid analysis. Ann Intern Med 2012; 156: 401-3.
8. Hamano H, Umemura T, Uehara T, Kawa S, Kiyosawa K. IgG4-related sclerosing cholangitis should be included as an exclusion criterion for the diagnosis of primary sclerosing cholangitis. Am J Gastroenterol 2007; 102: 691-2.
9. Wallace ZS, Khosroshahi A, Jakobiec FA, Deshpande V, Hatton MP, Ritter J., et al. IgG4-related systemic disease as a cause of idiopathic orbital inflammation, including orbital myositis, and trigeminal nerve involvement. Surv Ophthalmol 2012; 57: 26-33.
10. Della-Torre E, Mattoo H, Mahajan VS, Deshpande V, Krause D, Song P., et al. IgG4-related midline destructive lesion. Ann Rheum Dis 2014; 73: 1434-6.
11. Carruthers MN, Khosroshahi A, Augustin T, Deshpande V, Stone JH. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis 2015; 74: 14-18.
12. Ngwa TN, Law R, Murray D, Chari ST. Serum immunoglobulin G4 level is a poor predictor of immunoglobulin G4-related disease. Pancreas 2014; 43: 704-7.
13. Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T., et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol 2012; 25: 1181-92.
14. Kamisawa T, Okazaki K, Kawa S, Shimosegawa T, Tanaka M. Japanese consensus guidelines for management of autoimmune pancreatitis. III. Treatment and prognosis of AIP. J Gastroenterol 2010; 45: 471-7.
15. Ghazale A, Chari ST, Zhang L, Smyrk TC, Takahashi N, Levy MJ., et al. Immunoglobulin G4-Associated cholangitis: clinical profile and response to therapy. Gastroenterology 2008; 134: 706-15.
16. Hart PA, Kamisawa T, Brugge WR, Chung JB, Culver EL, Czakó L., et al. Long-Term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut 2013; 62: 1771-6.
17. Khosroshahi A, Stone JH. Treatment approaches to IgG4-related systemic disease. Curr Opin Rheumatol 2011; 23: 67-71.
18. Della-Torre E, Campochiaro C, Bozzolo EP, Dagna L, Scotti R, Nicoletti R., et al. Methotrexate for maintenance of remission in IgG4-related disease. Rheumatology (Oxford). Published online: 2 July 2015. doi: 10.1093/rheumatology/kev244
19. Khosroshahi A, Bloch DB, Deshpande V, Stone JH. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum 2010; 62: 1755-62.
20. Carruthers MN, Topazian MD, Khosroshahi A, Witzig TE, Wallace ZS, Hart PA., et al. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis 2015; 74: 1171-7.
21. Della-Torre E, Feeney E, Deshpande V, Mattoo H, Mahajan V, Kulikova M., et al. B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease. Ann Rheum Dis. Published online: 20 August 2014. doi: 10.1136/annrheumdis-2014-205799.
22. Huggett MT, Culver EL, Kumar M, Hurst JM, Rodriguez-Justo M, Chapman MH., et al. Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort. Am J Gastroenterol 2014; 109: 1675-83.
23. Ebbo M, Daniel L, Pavic M, Sève P, Hamidou M, Andres E., et al. IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry. Medicine (Baltimore) 2012; 91: 49-56.
24. Frulloni L, Lunardi C, Simone R, Dolcino M, Scattolini C, Falconi M., et al. Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med 2009; 361: 2135-42.
25. Caso F, Fiocco U, Costa L, Sfriso P, Punzi L, Doria A. Successful use of rituximab in a young patient with immunoglobulin G4-related disease and refractory scleritis. Joint Bone Spine 2014; 81: 190-2.
26. Maida M, Macaluso FS, Cabibbo G, Lo Re G, Alessi N. Progressive multi-organ expression of immunoglobulin G4-related disease: A case report. World J Hepatol 2013; 5: 336-9.
27. Marando A, D'Ambrosio G, Catanzaro F, La Rosa S, Sessa F. IgG4-related disease of the ureter: report of two cases and review of the literature. Virchows Arch 2013; 462: 673-8.
28. Lombardi C, Belli D, Facchetti F, Passalacqua G. IgG4: not only for allergists. Int J Immunopathol Pharmacol 2013; 26: 571-4.
29. Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T., et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 2012; 22: 21-30.
30. Shimosegawa T, Chari ST, Frulloni L, Kamisawa T, Kawa S, Mino-Kenudson M., et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 2011; 40: 352-8.
31. Carruthers MN, Stone JH, Deshpande V, Khosroshahi A. Development of an IgG4-RD responder index. Int J Rheumatol 2012; 2012: 259408.
32. Johansson SG, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T., et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001; 56: 813-24.
33. Wallace ZS, Mattoo H, Carruthers M, Mahajan VS, Della Torre E, Lee H., et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis 2015; 74: 190-5.
34. Della Torre E, Mattoo H, Mahajan VS, Carruthers M, Pillai S, Stone JH. Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease. Allergy 2014; 69: 269-72.
35. Dahl R, Andersen PS, Chivato T, Valovirta E, de Monchy J. National prevalence of respiratory allergic disorders. Respir Med 2004; 98: 398-403.
36. Moriyama M, Furukawa S, Kawano S, Goto Y, Kiyoshima T, Tanaka A., et al. The diagnostic utility of biopsies from the submandibular and labial salivary glands in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikuliczs disease. Int J Oral Maxillofac Surg 2014; 43: 1276-81.
37. Hiepe F, Dörner T, Hauser AE, Hoyer BF, Mei H, Radbruch A. Long-lived autoreactive plasma cells drive persistent autoimmune inflammation. Nat Rev Rheumatol 2011; 7: 170-8.
38. De Luna G, Terrier B, Kaminsky P, Le Quellec A, Maurier F, Solans R., et al. Central nervous system involvement of granulomatosis with polyangiitis: clinical-radiological presentation distinguishes different outcomes. Rheumatology (Oxford) 2015; 54: 424-32.